A Trial of Intra-pleuraL OK-432 Therapy in mesothelioma (TILT): A feasibility study using the 'trial within a cohort' methodology

Trial Profile

A Trial of Intra-pleuraL OK-432 Therapy in mesothelioma (TILT): A feasibility study using the 'trial within a cohort' methodology

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 03 Jan 2018

At a glance

  • Drugs Picibanil (Primary)
  • Indications Mesothelioma
  • Focus Adverse reactions
  • Acronyms TILT
  • Most Recent Events

    • 12 Dec 2017 New trial record
    • 05 Dec 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top